CCTG OV.25, STICS and STONES

Trial Description: 
A randomized phase II double-blind placebo-controlled trial of Acetylsalicylic acid (ASA) in chemoprevention of ovarian cancer in women with BRCA1/2 mutations
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Recruiting
Contact person: